A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china
2011 · BMC Cancer · 230 citations
https://doi.org/10.1186/1471-2407-11-364
H
Hui Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
187
Papers
3.2K
Citations
33
h-index
68
i10-index
Hui Li is an academic researcher from Central South University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Lung Cancer Diagnosis and Treatment & RNA modifications and cancer. The author has an h-index of 33, co-authored 159 publications.
ORCID: 0000-0002-8743-7146Papers by this author
worksEmodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation
2016 · BMC Cancer · 86 citations
https://doi.org/10.1186/s12885-016-2640-3
Targeting YAP in malignant pleural mesothelioma
2017 · Journal of Cellular and Molecular Medicine · 58 citations
https://doi.org/10.1111/jcmm.13182
Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: Glutathione reduction and MRP1 downregulation
2012 · Oncology Reports · 42 citations
https://doi.org/10.3892/or.2012.2156
Pulmonary benign metastasizing leiomyoma: a case report and review of the literature
2012 · World Journal of Surgical Oncology · 29 citations
https://doi.org/10.1186/1477-7819-10-268
PLSCR1/IP3R1/Ca2+ axis contributes to differentiation of primary AML cells induced by wogonoside
2017 · Cell Death and Disease · 23 citations
https://doi.org/10.1038/cddis.2017.175
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat